Clinical Trial Update: Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

View source ↗

Summary

A recruiting clinical trial aims to identify multiple pulmonary diseases by using volatile organic compound biomarkers in exhaled breath.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema
• Interstitial Lung Disease
• Lung Cancer
• Pulmonary Embolism
• Pulmonary Fibrosis
• Pulmonary Tuberculosis

Snippet

Sponsor: ChromX Health | Conditions: Lung Cancer, Lung Infection | Status: RECRUITING